Hong Kong stocks' innovative drug sector continued to strengthen in the afternoon, with Innovent Biologics rising by more than 10%
2025-04-22 13:35:51

The Hong Kong stock market's innovative drug sector continued to strengthen in the afternoon, with Innovent Biologics and Innovent Biologics rising by more than 10%, BeiGene rising by nearly 10%, and CSPC Pharmaceutical Group, Rongchang Biopharma, and WuXi Biologics all rising sharply.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
ASIA TECH WIRE

Grasp technology trends

Download